Bausch Health (BHC) Recent Trading Surge: The Reason
As of the last check, Bausch Health Companies Inc. (NYSE: BHC) shares were up 9.25% at $7.32 following a tentative regulatory approval. At the close of the previous session, BHC’s stock was trading at $6.70. What has BHC received approval for? Tentative approval of Norwich Pharmaceuticals’ rifaximin 200 mg product by the US Food and […]